These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 8391403)

  • 41. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure.
    Zelis R; Mason DT; Braunwald E
    J Clin Invest; 1968 Apr; 47(4):960-70. PubMed ID: 5641631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients.
    Taddei S; Virdis A; Mattei P; Ghiadoni L; Sudano I; Salvetti A
    Circulation; 1996 Sep; 94(6):1298-303. PubMed ID: 8822983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
    Taddei S; Virdis A; Mattei P; Natali A; Ferrannini E; Salvetti A
    Circulation; 1995 Nov; 92(10):2911-8. PubMed ID: 7586259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension.
    Panza JA; Quyyumi AA; Brush JE; Epstein SE
    N Engl J Med; 1990 Jul; 323(1):22-7. PubMed ID: 2355955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes.
    Wotherspoon F; Browne DL; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
    Diabet Med; 2005 Jun; 22(6):697-702. PubMed ID: 15910619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.
    Panza JA; García CE; Kilcoyne CM; Quyyumi AA; Cannon RO
    Circulation; 1995 Mar; 91(6):1732-8. PubMed ID: 7882481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is nitric oxide involved in cutaneous vasodilation during body heating in humans?
    Dietz NM; Rivera JM; Warner DO; Joyner MJ
    J Appl Physiol (1985); 1994 May; 76(5):2047-53. PubMed ID: 7520431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sympathetic activation restrains endothelium-mediated muscle vasodilatation in heart failure patients.
    Santos AC; Alves MJ; Rondon MU; Barretto AC; Middlekauff HR; Negrão CE
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H593-9. PubMed ID: 15778282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for nitric oxide-mediated sympathetic forearm vasodiolatation in humans.
    Dietz NM; Engelke KA; Samuel TT; Fix RT; Joyner MJ
    J Physiol; 1997 Jan; 498 ( Pt 2)(Pt 2):531-40. PubMed ID: 9032700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide.
    Meredith IT; Currie KE; Anderson TJ; Roddy MA; Ganz P; Creager MA
    Am J Physiol; 1996 Apr; 270(4 Pt 2):H1435-40. PubMed ID: 8967386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An inhibitor of inducible nitric oxide synthase decreases forearm blood flow in patients with congestive heart failure.
    Ishibashi Y; Shimada T; Murakami Y; Takahashi N; Sakane T; Sugamori T; Ohata S; Inoue S; Ohta Y; Nakamura K; Shimizu H; Katoh H; Hashimoto M
    J Am Coll Cardiol; 2001 Nov; 38(5):1470-6. PubMed ID: 11691525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men.
    Nietlispach F; Julius B; Schindler R; Bernheim A; Binkert C; Kiowski W; Brunner-La Rocca HP
    Hypertension; 2007 Jul; 50(1):82-8. PubMed ID: 17502494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin II does not affect endothelial tone in Type 1 diabetes-results of a double-blind placebo controlled trial.
    Browne DL; Meeking DR; Allard SE; Munday JL; Shaw KM; Cummings MH
    Diabet Med; 2006 Jan; 23(1):53-9. PubMed ID: 16409566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.
    Linder L; Kiowski W; Bühler FR; Lüscher TF
    Circulation; 1990 Jun; 81(6):1762-7. PubMed ID: 2344673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men.
    Dishy V; Sofowora G; Harris PA; Kandcer M; Zhan F; Wood AJ; Stein CM
    Clin Pharmacol Ther; 2001 Sep; 70(3):270-9. PubMed ID: 11557915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beta adrenergic-mediated vasodilator response to insulin in the human forearm.
    Creager MA; Liang CS; Coffman JD
    J Pharmacol Exp Ther; 1985 Dec; 235(3):709-14. PubMed ID: 3001273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans.
    Duffy SJ; Tran BT; New G; Tudball RN; Esler MD; Harper RW; Meredith IT
    Am J Physiol; 1998 Apr; 274(4):H1174-83. PubMed ID: 9575920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired effectiveness of nitric oxide-donors in resistance arteries of patients with arterial hypertension.
    Preik M; Kelm M; Feelisch M; Strauer BE
    J Hypertens; 1996 Jul; 14(7):903-8. PubMed ID: 8818930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Moderate, Short-Term, Local Hyperglycemia Attenuates Forearm Endothelium-Dependent Vasodilation After Transient Ischemia-Reperfusion in Human Volunteers.
    Ebert TJ; Novalija J; Barney JA; Uhrich TD; Arain SR; Freed JK; Pagel PS
    J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1649-1655. PubMed ID: 28284926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maintenance of forearm vasodilator action of atrial natriuretic factor in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Kubo SH; Atlas SA; Laragh JH; Cody RJ
    Am J Cardiol; 1992 May; 69(16):1306-9. PubMed ID: 1533988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.